Co-founder & CEO Joshua Blight talks about Baseimmune's platform, which was inspired by the work that happened during COVID both in the...

CEO David Venables describes Laverock's platform that repurposed miRNA to reprogram cells in a highly specific way. It's own lead...

Dr. Rich Ferrie gives BiotechTV a preview of the new facilities and describes how it is aimed for growing companies. It has already...

Product manager Emmanuel Naouri walks us through the new instrument and its features, including consumables that can be stored at room...

Chief International Officer Bobby Soni describes all the different ways that BI supports entrepreneurs such as grants, facilities,...

Entrepreneurship and Business Development Director Marco Delise describes the facilities available at SBC and the types of companies that...

Laura Niklason shows us what Humacyte's Human Acellular Vessel (HAV) looks like, describes how it is manufactured, explains its utility,...

Dean of Biomedical Studies Kristy Shuda McGuire describes how the BTT program trains community college and other students in lab work,...

Thomas Renn, Head of Europe for Breakthrough Properties, introduces us to this state-of-the-art facility that will encompass 214,000...

CEO Derek Jones describes how the campus is designed to augment the public research taking place at Babraham Institute with a community of s

Professor Matthew Wood explains the idea behind this biotech startup incubator and also shares his expertise on the latest in neuroscience.

CEO Murat Cirit describes how the liver tissue chip and accompanying software is meant to improve the quality of preclinical research.

Chaitan Khosla, Director of the Innovative Medicines Accelerator, describes how Stanford goes extra lengths to turn its research into...

BiotechTV visited the Freemont, CA headquarters of Ultima Genomics and spoke with CEO Gilad Almogy about their approach.

Cognito CEO Brent Vaughan introduces the company's device and walks us through the randomized P2 study.

ChemoMetec's VP of Operations Jonas la Cour walks us through his company's NucleoCounter technology.

LumaCyte SVP Colin Hebert walks us through the company's Radiance platform instrument.

Lonza Sales Manager Jerry Jiang walks us through the company's automated cell therapy manufacturing platform.

Thermo Fisher Scientific Senior Manager Russell Jerres walks us through the DynaCellect, Rotea, and Xenon systems.

Stephen Dilly describes how Codexis is trying help RNA companies use enzymes to more efficiently make oligonucleotides.